OMCL Stock Summary and Trading Ideas (Omnicell | NASDAQ:OMCL)

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Omnicell trades on the NASDAQ stock market under the symbol OMCL.

As of July 14, 2026, OMCL stock price declined to $45.94 with 610,742 million shares trading.

OMCL has a beta of 1.20, meaning it tends to be more sensitive to market movements. OMCL has a correlation of 0.08 to the broad based SPY ETF.

OMCL has a market cap of $2.09 billion. This is considered a Mid Cap stock.

Last quarter Omnicell reported $310 million in Revenue and $.55 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.26.

In the last 3 years, OMCL traded as high as $73.52 and as low as $22.66.

The top ETF exchange traded funds that OMCL belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.

OMCL has outperformed the market in the last year with a price return of +60.1% while the SPY ETF gained +21.8%. OMCL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +31.2% and +12.3%, respectively, while the SPY returned +9.9% and +1.5%, respectively.

OMCL support price is $45.30 and resistance is $48.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OMCL shares will trade within this expected range on the day.